1. Home
  2. Browse Decisions
  3. GALDERMA LABORATORIES, L.P. v. TEVA PHARMACEUTICALS USA, INC.
 

GALDERMA LABORATORIES, L.P. v. TEVA PHARMACEUTICALS USA, INC.

Nos. 2019-2396, 2020-1213.

GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA SKIN HEALTH S.A., Plaintiffs-Appellants v. TEVA PHARMACEUTICALS USA, INC., Defendant-Cross-Appellant

United States Court of Appeals, Federal Circuit.

Decided: January 29, 2020.

Attorney(s) appearing for the Case

JAMIL ALIBHAI , Munck Wilson Mandala, LLP, Dallas, TX, for plaintiffs-appellants. Also represented by KELLY P. CHEN , CHASE COBERN , CHAD RAY , MICHAEL CRAIG WILSON ; EVAN D. DIAMOND , GERALD J. FLATTMANN, JR. , VANESSA YEN , King & Spalding LLP, New York, NY.

JOHN C. O'QUINN , Kirkland & Ellis LLP, Washington, DC, for defendant-cross-appellant. Also represented by WILLIAM H. BURGESS ; LEORA BEN-AMI, New York, NY.

Before MOORE, O'MALLEY, AND STOLL, Circuit Judges.

NOTE: This disposition is nonprecedential.

This patent infringement suit arises from the filing of Teva Pharmaceuticals USA, Inc.'s ("Teva's") Abbreviated New Drug Application ("ANDA") No. 210019. In its ANDA, Teva seeks approval to market a generic version of Soolantra®, a pharmaceutical product marketed...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases